In our cohort of 1862 NSCLC patients, only seven tumors were found to harbor β2-microglobulin (B2M) mutations and there was no difference among different EGFR mutant subtypes (Supplementary Table 4). The gene discussed is B2M; the disease is non-small cell lung carcinoma.